Literature DB >> 17607044

Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.

Rajesh Nayak1, Veronica Call, Pravin Kaldhone, Cynthia Tyler, Gwendolyn Anderson, Sarah Phillips, Khalil Kerdahi, Steven L Foley.   

Abstract

OBJECTIVE: Disk diffusion and broth dilution assays are conventionally used for antimicrobial susceptibility testing (AST) of bacteria. The goal of this study was to determine the correlation of results from different AST methods for the Salmonella enterica serovar Heidelberg.
DESIGN: S. enterica serovar Heidelberg (n=105) strains were tested using 4 different AST methods: agar disk diffusion, broth microdilution using Sensititre with the NARMS (CMV1AGNF) panel, manual broth microdilution and Vitek with GNS-207 cards.
METHODS: AST was performed using standardized methods and Clinical and Laboratory Standards Institute recommended quality control organisms. Eight drugs were common to all testing methods including amikacin, amoxicillin/clavulanic acid, ampicillin, chloramphenicol, ciprofloxacin, gentamicin, tetracycline and trimethoprim/sulfamethoxazole.
RESULTS: No resistance to amikacin and ciprofloxacin was detected. Overall, the agreement of the AST results among all four methods for the drugs tested was: amikacin (100%), amoxicillin/clavulanic acid (96.1%), ampicillin (97.1%), chloramphenicol (96.2%), ciprofloxacin (100%), gentamicin (80.0%), tetracycline (80.0%) and trimethoprim/sulfamethoxazole (94.3%). There was 97.1%, 95.5% and 98.0% overall agreement between the reference diffusion method and the manual broth microdilution, Sensititre microdilution and Vitek methods, respectively.
CONCLUSION: The study indicated that AST methods correlated with one another when testing S. enterica serovar Heidelberg isolates, with a few exceptions. In general, discrepancies among the methods were due to isolates being interpreted as intermediately susceptible or due to an increased number of resistances detected with Sensititre and a lower number with Vitek.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607044      PMCID: PMC1905935          DOI: 10.3121/cmr.2007.725

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  19 in total

Review 1.  The National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria, 1996-1999: surveillance for action.

Authors:  N N Marano; S Rossiter; K Stamey; K Joyce; T J Barrett; L K Tollefson; F J Angulo
Journal:  J Am Vet Med Assoc       Date:  2000-12-15       Impact factor: 1.936

2.  Bioterrorism. Researchers question obsession with Cipro.

Authors:  M Enserink
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

Review 3.  Confronting bioterrorism: physicians on the front line.

Authors:  Prathibha Varkey; Gregory A Poland; Franklin R Cockerill; Thomas F Smith; Philip T Hagen
Journal:  Mayo Clin Proc       Date:  2002-07       Impact factor: 7.616

Review 4.  Optimal use of antibiotic resistance surveillance systems.

Authors:  I A Critchley; J A Karlowsky
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

5.  International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada.

Authors:  Frank M Aarestrup; Henrik Hasman; Inger Olsen; Gitte Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Harmonization of antibiotic susceptibility testing for Salmonella: results of a study by 18 national reference laboratories within the European Union-funded Enter-net group.

Authors:  E J Threlfall; I S Fisher; L R Ward; H Tschäpe; P Gerner-Smidt
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

7.  Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  James A Karlowsky; Mellany K Weaver; Clyde Thornsberry; Michael J Dowzicky; Mark E Jones; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  The incidence of antimicrobial-resistant Salmonella spp on freshly processed poultry from US Midwestern processing plants.

Authors:  C M Logue; J S Sherwood; P A Olah; L M Elijah; M R Dockter
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

9.  Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.

Authors:  Christine D Steward; Jasmine M Mohammed; Jana M Swenson; Sheila A Stocker; Portia P Williams; Robert P Gaynes; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Genetic diversity and virulence gene determinants of antibiotic-resistant Salmonella isolated from preharvest turkey production sources.

Authors:  R Nayak; T Stewart; R-F Wang; J Lin; C E Cerniglia; P B Kenney
Journal:  Int J Food Microbiol       Date:  2004-02-15       Impact factor: 5.277

View more
  2 in total

1.  Agar disk diffusion and automated microbroth dilution produce similar antimicrobial susceptibility testing results for Salmonella serotypes Newport, Typhimurium, and 4,5,12:i-, but differ in economic cost.

Authors:  Karin Hoelzer; Kevin J Cummings; Lorin D Warnick; Ynte H Schukken; Julie D Siler; Yrjo T Gröhn; Margaret A Davis; Tom E Besser; Martin Wiedmann
Journal:  Foodborne Pathog Dis       Date:  2011-08-30       Impact factor: 3.171

2.  The prevalence of multidrug resistance is higher among bovine than human Salmonella enterica serotype Newport, Typhimurium, and 4,5,12:i:- isolates in the United States but differs by serotype and geographic region.

Authors:  K Hoelzer; Y Soyer; L D Rodriguez-Rivera; K J Cummings; P L McDonough; D J Schoonmaker-Bopp; T P Root; N B Dumas; L D Warnick; Y T Gröhn; M Wiedmann; K N K Baker; T E Besser; D D Hancock; M A Davis
Journal:  Appl Environ Microbiol       Date:  2010-07-16       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.